Why Psychedelic Medicine Needs Training and Safety With Dr. Signi Goldman

Living Medicine

Dr. Signi Goldman, MD, is a board-certified psychiatrist and the Co-founder and Medical Director of Living Medicine Institute, which offers psychedelic-assisted psychotherapy training programs. As a certified provider for psychedelic-assisted therapy and research, she has practiced in various clinical settings, including hospital systems and alternative treatment settings. Dr. Goldman also serves as a Psychiatrist and Psychotherapist for Concierge Medicine and Psychiatry’s Ketamine-Assisted Psychotherapy Program for Mental Health.

In this episode…

Cutting-edge studies show that ketamine and other psychedelic-assisted psychotherapy modalities are effective in treating various mental health conditions. While this technique is promising, it lacks training programs to execute it effectively. If you’re interested in this space, how can you integrate psychedelic-assisted psychotherapy practices into your approach?

As an early adopter of ketamine-assisted therapy, Dr. Signi Goldman says this treatment can’t be used on its own; instead, it must be integrated into an established treatment program. She emphasizes using scientific evidence in your approach, monitoring and optimizing dosage ranges to prevent addiction risks. Providers must also engage in the treatment drug in controlled settings to provide authentic treatment, learn about the drug’s effects, and help the patient navigate their altered state.

In this episode of Living Medicine, Chad Franzen of Rise25 interviews Dr. Signi Goldman, the Co-founder and Medical Director of Living Medicine Institute, about the safe use of psychedelics in psychotherapy practices. She talks about her work as a rite of passage guide, her teaching and certification programs for psychedelic-assisted therapy, and the role of this modality in future psychiatric treatment plans.